文献速递免疫规划

绵羊蓝舌病4型和8型灭活疫苗不同接种方案免疫原性比较

A comparison of different vaccination schemes used in sheep combining inactivated bluetongue vaccines against serotypes 4 and 8.
PubMed 文献 · Vaccine · 2019-08-17

在田间条件下测试了8种使用4种市售蓝舌病4型和8型灭活疫苗的接种方案,每组30只羊,共240只。所有疫苗组合耐受良好,同时双针注射加强免疫组(B组)在首免后26周产生最高中位血清型特异性滴度,首免后一年ELISA血清阳性率达100%。单次接种在首免后半年诱导的免疫原性与加强注射相当。

要点

  • 所有疫苗组合耐受良好,无不良事件报告。
  • 同时双针注射加强免疫组首免后26周中位滴度最高,一年后100%血清阳性。
  • 单次接种在首免后半年免疫原性与加强注射相当。

核心结论

  • 同时双针注射加强免疫方案在首免后26周产生最高中位血清型特异性滴度,首免后一年ELISA血清阳性率达100%。
  • 单次接种在首免后半年诱导的免疫原性与加强注射相当。
  • 不同部位或同一部位同时接种不同疫苗的免疫反应无显著差异。

研究设计与样本

  • 田间试验,8种接种方案,每组30只羊,共240只羊。
  • 使用4种市售蓝舌病4型和8型灭活疫苗,3种组合方式。
  • 所有羊用ELISA检测免疫反应,每组5-6只羊(共45只)做血清中和试验。

主要发现

  • 所有疫苗组合所有羊均耐受良好。
  • 同时双针注射加强免疫组首免后26周中位血清型特异性滴度最高,首免后一年ELISA血清阳性率100%。
  • 单次接种在首免后半年免疫原性与加强注射相当。
  • 不同部位或同一部位同时接种不同疫苗的免疫反应无显著差异。
  • 方案2和3中血清型特异性中和抗体水平低,归因于多种可能影响免疫原性的因素。

临床怎么用

  • 绵羊蓝舌病4型和8型灭活疫苗可采用同时双针注射加强免疫方案以获得高且持久的免疫应答。
  • 单次接种在首免后半年内可提供与加强注射相当的免疫原性。

局限性

  • 方案2和3中血清型特异性中和抗体水平低,归因于多种可能影响免疫原性的因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Eight different vaccination schemes using four commercially available inactivated Bluetongue vaccines against serotypes 4 and 8 in three different combinations (setting 1-3) were tested under field conditions for their ability to generate a measurable immune response in sheep. Animals of setting 1 (groups A-D) were simultaneously vaccinated using either individual injections at different locations (groups A & D) or double injection by a twin-syringe (groups B & C). For both application methods, a one-shot vaccination (groups C & D) was compared to a boosted vaccination (groups A & B). Sheep of setting 2 (groups E-G) were vaccinated in an alternating, boosted pattern at fortnightly intervals starting with serotype 4 (groups E & F) or vice versa (group G). Group H of setting 3 was vaccinated simultaneously and vaccines were injected individually as a one-shot application. Each group consisted of 30 sheep. The immunogenic response was tested in all sheep (n = 240) by ELISA (IDScreen®Bluetongue Competition), while serum neutralisation tests were performed in five to six sheep from each group (n = 45). All vaccine combinations were well tolerated by all sheep. Of all vaccines and schemes described, the simultaneous double injected boosted vaccination of setting 1 (group B) yielded the highest median serotype-specific titres 26 weeks after the first vaccination (afv) and 100% seropositive animals (ELISA) one year afv. In setting 1, there were no relevant significant differences in the immunogenic response between simultaneously applied vaccines at different sites or at the same injection site. Importantly, a one-shot vaccination induced comparable immunogenicity to a boosted injection half a year afv. Low serotype-specific neutralising antibody levels were detected in settings 2 and 3 and are attributed to diverse factors which may have influenced the measured immunogenicity.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Hilke J, Strobel H, Woelke S, et al. A comparison of different vaccination schemes used in sheep combining inactivated bluetongue vaccines against serotypes 4 and 8. Vaccine. 2019. PMID: 31431410. doi:10.1016/j.vaccine.2019.08.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。